nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftazidime—SLC22A5—Dactinomycin—peripheral nervous system neoplasm	0.343	1	CbGbCtD
Ceftazidime—Vaginal infection—Doxorubicin—peripheral nervous system neoplasm	0.00093	0.00141	CcSEcCtD
Ceftazidime—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000925	0.00141	CcSEcCtD
Ceftazidime—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000921	0.0014	CcSEcCtD
Ceftazidime—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.000917	0.0014	CcSEcCtD
Ceftazidime—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000917	0.0014	CcSEcCtD
Ceftazidime—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000916	0.00139	CcSEcCtD
Ceftazidime—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000913	0.00139	CcSEcCtD
Ceftazidime—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000913	0.00139	CcSEcCtD
Ceftazidime—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00091	0.00138	CcSEcCtD
Ceftazidime—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00091	0.00138	CcSEcCtD
Ceftazidime—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000905	0.00138	CcSEcCtD
Ceftazidime—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000905	0.00138	CcSEcCtD
Ceftazidime—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000905	0.00138	CcSEcCtD
Ceftazidime—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000905	0.00138	CcSEcCtD
Ceftazidime—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.000902	0.00137	CcSEcCtD
Ceftazidime—Coma—Doxorubicin—peripheral nervous system neoplasm	0.0009	0.00137	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000899	0.00137	CcSEcCtD
Ceftazidime—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000898	0.00137	CcSEcCtD
Ceftazidime—Phlebitis—Epirubicin—peripheral nervous system neoplasm	0.000897	0.00136	CcSEcCtD
Ceftazidime—Thrombophlebitis—Epirubicin—peripheral nervous system neoplasm	0.000892	0.00136	CcSEcCtD
Ceftazidime—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000888	0.00135	CcSEcCtD
Ceftazidime—Flushing—Etoposide—peripheral nervous system neoplasm	0.000885	0.00135	CcSEcCtD
Ceftazidime—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.000884	0.00135	CcSEcCtD
Ceftazidime—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000868	0.00132	CcSEcCtD
Ceftazidime—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000865	0.00132	CcSEcCtD
Ceftazidime—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000861	0.00131	CcSEcCtD
Ceftazidime—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000854	0.0013	CcSEcCtD
Ceftazidime—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000851	0.00129	CcSEcCtD
Ceftazidime—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00085	0.00129	CcSEcCtD
Ceftazidime—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00085	0.00129	CcSEcCtD
Ceftazidime—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000849	0.00129	CcSEcCtD
Ceftazidime—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000844	0.00128	CcSEcCtD
Ceftazidime—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000844	0.00128	CcSEcCtD
Ceftazidime—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000843	0.00128	CcSEcCtD
Ceftazidime—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000836	0.00127	CcSEcCtD
Ceftazidime—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000833	0.00127	CcSEcCtD
Ceftazidime—Phlebitis—Doxorubicin—peripheral nervous system neoplasm	0.00083	0.00126	CcSEcCtD
Ceftazidime—Hot flush—Epirubicin—peripheral nervous system neoplasm	0.000826	0.00126	CcSEcCtD
Ceftazidime—Thrombophlebitis—Doxorubicin—peripheral nervous system neoplasm	0.000826	0.00126	CcSEcCtD
Ceftazidime—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00082	0.00125	CcSEcCtD
Ceftazidime—Menopausal symptoms—Epirubicin—peripheral nervous system neoplasm	0.000819	0.00125	CcSEcCtD
Ceftazidime—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000819	0.00125	CcSEcCtD
Ceftazidime—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000818	0.00124	CcSEcCtD
Ceftazidime—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000817	0.00124	CcSEcCtD
Ceftazidime—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000813	0.00124	CcSEcCtD
Ceftazidime—Renal impairment—Epirubicin—peripheral nervous system neoplasm	0.000812	0.00124	CcSEcCtD
Ceftazidime—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000811	0.00123	CcSEcCtD
Ceftazidime—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000811	0.00123	CcSEcCtD
Ceftazidime—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00081	0.00123	CcSEcCtD
Ceftazidime—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00081	0.00123	CcSEcCtD
Ceftazidime—Pain—Dactinomycin—peripheral nervous system neoplasm	0.0008	0.00122	CcSEcCtD
Ceftazidime—Pruritus—Melphalan—peripheral nervous system neoplasm	0.0008	0.00122	CcSEcCtD
Ceftazidime—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00079	0.0012	CcSEcCtD
Ceftazidime—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000788	0.0012	CcSEcCtD
Ceftazidime—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000785	0.00119	CcSEcCtD
Ceftazidime—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000784	0.00119	CcSEcCtD
Ceftazidime—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000784	0.00119	CcSEcCtD
Ceftazidime—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000781	0.00119	CcSEcCtD
Ceftazidime—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000779	0.00119	CcSEcCtD
Ceftazidime—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000773	0.00118	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000766	0.00117	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000765	0.00116	CcSEcCtD
Ceftazidime—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.000764	0.00116	CcSEcCtD
Ceftazidime—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000763	0.00116	CcSEcCtD
Ceftazidime—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.000758	0.00115	CcSEcCtD
Ceftazidime—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000757	0.00115	CcSEcCtD
Ceftazidime—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000757	0.00115	CcSEcCtD
Ceftazidime—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.000751	0.00114	CcSEcCtD
Ceftazidime—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000751	0.00114	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000749	0.00114	CcSEcCtD
Ceftazidime—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000743	0.00113	CcSEcCtD
Ceftazidime—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000742	0.00113	CcSEcCtD
Ceftazidime—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00074	0.00113	CcSEcCtD
Ceftazidime—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00074	0.00113	CcSEcCtD
Ceftazidime—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000739	0.00113	CcSEcCtD
Ceftazidime—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000734	0.00112	CcSEcCtD
Ceftazidime—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000729	0.00111	CcSEcCtD
Ceftazidime—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000728	0.00111	CcSEcCtD
Ceftazidime—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000728	0.00111	CcSEcCtD
Ceftazidime—Rash—Topotecan—peripheral nervous system neoplasm	0.000728	0.00111	CcSEcCtD
Ceftazidime—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000727	0.00111	CcSEcCtD
Ceftazidime—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000725	0.0011	CcSEcCtD
Ceftazidime—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000724	0.0011	CcSEcCtD
Ceftazidime—Headache—Topotecan—peripheral nervous system neoplasm	0.000723	0.0011	CcSEcCtD
Ceftazidime—Rash—Tretinoin—peripheral nervous system neoplasm	0.000722	0.0011	CcSEcCtD
Ceftazidime—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000722	0.0011	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000722	0.0011	CcSEcCtD
Ceftazidime—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000721	0.0011	CcSEcCtD
Ceftazidime—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000721	0.0011	CcSEcCtD
Ceftazidime—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000719	0.00109	CcSEcCtD
Ceftazidime—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000719	0.00109	CcSEcCtD
Ceftazidime—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000718	0.00109	CcSEcCtD
Ceftazidime—Headache—Tretinoin—peripheral nervous system neoplasm	0.000717	0.00109	CcSEcCtD
Ceftazidime—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000717	0.00109	CcSEcCtD
Ceftazidime—Pain—Vincristine—peripheral nervous system neoplasm	0.000715	0.00109	CcSEcCtD
Ceftazidime—Rash—Melphalan—peripheral nervous system neoplasm	0.000713	0.00108	CcSEcCtD
Ceftazidime—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000712	0.00108	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00071	0.00108	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000702	0.00107	CcSEcCtD
Ceftazidime—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000696	0.00106	CcSEcCtD
Ceftazidime—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000691	0.00105	CcSEcCtD
Ceftazidime—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00069	0.00105	CcSEcCtD
Ceftazidime—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000689	0.00105	CcSEcCtD
Ceftazidime—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000686	0.00104	CcSEcCtD
Ceftazidime—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000686	0.00104	CcSEcCtD
Ceftazidime—Nausea—Topotecan—peripheral nervous system neoplasm	0.000686	0.00104	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000684	0.00104	CcSEcCtD
Ceftazidime—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00068	0.00103	CcSEcCtD
Ceftazidime—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00068	0.00103	CcSEcCtD
Ceftazidime—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000677	0.00103	CcSEcCtD
Ceftazidime—Nausea—Melphalan—peripheral nervous system neoplasm	0.000671	0.00102	CcSEcCtD
Ceftazidime—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000664	0.00101	CcSEcCtD
Ceftazidime—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000663	0.00101	CcSEcCtD
Ceftazidime—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000661	0.00101	CcSEcCtD
Ceftazidime—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000661	0.00101	CcSEcCtD
Ceftazidime—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000661	0.00101	CcSEcCtD
Ceftazidime—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000658	0.001	CcSEcCtD
Ceftazidime—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000644	0.000979	CcSEcCtD
Ceftazidime—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00064	0.000974	CcSEcCtD
Ceftazidime—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000639	0.000973	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000638	0.000971	CcSEcCtD
Ceftazidime—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000634	0.000965	CcSEcCtD
Ceftazidime—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000633	0.000963	CcSEcCtD
Ceftazidime—Pain—Cisplatin—peripheral nervous system neoplasm	0.000632	0.000962	CcSEcCtD
Ceftazidime—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000624	0.00095	CcSEcCtD
Ceftazidime—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000616	0.000937	CcSEcCtD
Ceftazidime—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000614	0.000934	CcSEcCtD
Ceftazidime—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000612	0.000931	CcSEcCtD
Ceftazidime—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000608	0.000926	CcSEcCtD
Ceftazidime—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000595	0.000906	CcSEcCtD
Ceftazidime—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000595	0.000906	CcSEcCtD
Ceftazidime—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000595	0.000905	CcSEcCtD
Ceftazidime—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000594	0.000903	CcSEcCtD
Ceftazidime—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.00059	0.000898	CcSEcCtD
Ceftazidime—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00059	0.000898	CcSEcCtD
Ceftazidime—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000587	0.000893	CcSEcCtD
Ceftazidime—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000585	0.00089	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000585	0.00089	CcSEcCtD
Ceftazidime—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000585	0.000889	CcSEcCtD
Ceftazidime—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00058	0.000883	CcSEcCtD
Ceftazidime—Pain—Etoposide—peripheral nervous system neoplasm	0.000579	0.000881	CcSEcCtD
Ceftazidime—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000578	0.000879	CcSEcCtD
Ceftazidime—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000574	0.000873	CcSEcCtD
Ceftazidime—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000572	0.000871	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000563	0.000857	CcSEcCtD
Ceftazidime—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000556	0.000846	CcSEcCtD
Ceftazidime—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000556	0.000845	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000554	0.000843	CcSEcCtD
Ceftazidime—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000553	0.000841	CcSEcCtD
Ceftazidime—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000552	0.00084	CcSEcCtD
Ceftazidime—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000551	0.000838	CcSEcCtD
Ceftazidime—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000551	0.000838	CcSEcCtD
Ceftazidime—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000547	0.000833	CcSEcCtD
Ceftazidime—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000547	0.000832	CcSEcCtD
Ceftazidime—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000546	0.000831	CcSEcCtD
Ceftazidime—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000545	0.000829	CcSEcCtD
Ceftazidime—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000544	0.000827	CcSEcCtD
Ceftazidime—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000542	0.000824	CcSEcCtD
Ceftazidime—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000538	0.000819	CcSEcCtD
Ceftazidime—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000537	0.000817	CcSEcCtD
Ceftazidime—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000537	0.000817	CcSEcCtD
Ceftazidime—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000536	0.000815	CcSEcCtD
Ceftazidime—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000536	0.000815	CcSEcCtD
Ceftazidime—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000534	0.000813	CcSEcCtD
Ceftazidime—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000532	0.000809	CcSEcCtD
Ceftazidime—Rash—Vincristine—peripheral nervous system neoplasm	0.000527	0.000802	CcSEcCtD
Ceftazidime—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000527	0.000802	CcSEcCtD
Ceftazidime—Headache—Vincristine—peripheral nervous system neoplasm	0.000524	0.000797	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000521	0.000793	CcSEcCtD
Ceftazidime—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000515	0.000784	CcSEcCtD
Ceftazidime—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000514	0.000782	CcSEcCtD
Ceftazidime—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000506	0.00077	CcSEcCtD
Ceftazidime—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000505	0.000769	CcSEcCtD
Ceftazidime—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000499	0.000759	CcSEcCtD
Ceftazidime—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000497	0.000756	CcSEcCtD
Ceftazidime—Nausea—Vincristine—peripheral nervous system neoplasm	0.000497	0.000756	CcSEcCtD
Ceftazidime—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000496	0.000755	CcSEcCtD
Ceftazidime—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000495	0.000752	CcSEcCtD
Ceftazidime—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000485	0.000738	CcSEcCtD
Ceftazidime—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000483	0.000735	CcSEcCtD
Ceftazidime—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000479	0.000729	CcSEcCtD
Ceftazidime—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00047	0.000715	CcSEcCtD
Ceftazidime—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000468	0.000711	CcSEcCtD
Ceftazidime—Rash—Cisplatin—peripheral nervous system neoplasm	0.000466	0.000709	CcSEcCtD
Ceftazidime—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000466	0.000709	CcSEcCtD
Ceftazidime—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000463	0.000705	CcSEcCtD
Ceftazidime—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000459	0.000698	CcSEcCtD
Ceftazidime—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000456	0.000693	CcSEcCtD
Ceftazidime—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000449	0.000683	CcSEcCtD
Ceftazidime—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000448	0.000682	CcSEcCtD
Ceftazidime—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000447	0.00068	CcSEcCtD
Ceftazidime—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000439	0.000668	CcSEcCtD
Ceftazidime—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000438	0.000667	CcSEcCtD
Ceftazidime—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000431	0.000655	CcSEcCtD
Ceftazidime—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000428	0.000651	CcSEcCtD
Ceftazidime—Rash—Etoposide—peripheral nervous system neoplasm	0.000427	0.00065	CcSEcCtD
Ceftazidime—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000427	0.000649	CcSEcCtD
Ceftazidime—Headache—Etoposide—peripheral nervous system neoplasm	0.000424	0.000646	CcSEcCtD
Ceftazidime—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000422	0.000641	CcSEcCtD
Ceftazidime—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000416	0.000634	CcSEcCtD
Ceftazidime—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000406	0.000617	CcSEcCtD
Ceftazidime—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000403	0.000613	CcSEcCtD
Ceftazidime—Nausea—Etoposide—peripheral nervous system neoplasm	0.000402	0.000612	CcSEcCtD
Ceftazidime—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000396	0.000602	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000393	0.000599	CcSEcCtD
Ceftazidime—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000385	0.000586	CcSEcCtD
Ceftazidime—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00038	0.000578	CcSEcCtD
Ceftazidime—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000373	0.000568	CcSEcCtD
Ceftazidime—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000372	0.000567	CcSEcCtD
Ceftazidime—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000372	0.000566	CcSEcCtD
Ceftazidime—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000369	0.000561	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.000554	CcSEcCtD
Ceftazidime—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000355	0.00054	CcSEcCtD
Ceftazidime—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000535	CcSEcCtD
Ceftazidime—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000345	0.000524	CcSEcCtD
Ceftazidime—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.000523	CcSEcCtD
Ceftazidime—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000341	0.000519	CcSEcCtD
Ceftazidime—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000341	0.000519	CcSEcCtD
Ceftazidime—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.0005	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000328	0.000499	CcSEcCtD
Ceftazidime—Pain—Epirubicin—peripheral nervous system neoplasm	0.000325	0.000494	CcSEcCtD
Ceftazidime—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.00048	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000472	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000462	CcSEcCtD
Ceftazidime—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000459	CcSEcCtD
Ceftazidime—Pain—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.000457	CcSEcCtD
Ceftazidime—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000457	CcSEcCtD
Ceftazidime—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000457	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000437	CcSEcCtD
Ceftazidime—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000426	CcSEcCtD
Ceftazidime—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000425	CcSEcCtD
Ceftazidime—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000423	CcSEcCtD
Ceftazidime—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000423	CcSEcCtD
Ceftazidime—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000269	0.000409	CcSEcCtD
Ceftazidime—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000395	CcSEcCtD
Ceftazidime—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000394	CcSEcCtD
Ceftazidime—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000382	CcSEcCtD
Ceftazidime—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000378	CcSEcCtD
Ceftazidime—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000367	CcSEcCtD
Ceftazidime—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000366	CcSEcCtD
Ceftazidime—Rash—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000364	CcSEcCtD
Ceftazidime—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000364	CcSEcCtD
Ceftazidime—Headache—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000362	CcSEcCtD
Ceftazidime—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000354	CcSEcCtD
Ceftazidime—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000343	CcSEcCtD
Ceftazidime—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.00034	CcSEcCtD
Ceftazidime—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000337	CcSEcCtD
Ceftazidime—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000337	CcSEcCtD
Ceftazidime—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.000335	CcSEcCtD
Ceftazidime—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000318	CcSEcCtD
